COPS5 and hepatocellular carcinoma: Likewise, Jab1/CSN5 silencing reverses the sorafenib resistance of HCC cells and downregulates multi-drug-resistance proteins, including adenosine triphosphate binding cassette (ABC)B1, ABCG2, and ABCC2.